Smith Group Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Smith Group Asset Management's LMAT Position: Q1 2026 in Review
Smith Group Asset Management increased its LeMaitre Vascular (LMAT) stake by 69% in Q1 2026, buying an estimated $272K and bringing the position to 6,985 shares worth $763K. The position accounts for 0.04% of the portfolio, ranked #105.
Smith Group Asset Management first reported a position in LMAT in Q2 2017 and has held it in 9 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Smith Group Asset Management held 6,985 shares of LeMaitre Vascular worth $763K as of Q1 2026.
- Smith Group Asset Management bought 2,851 LeMaitre Vascular shares in Q1 2026, an estimated $272K.
- LeMaitre Vascular made up 0.04% of Smith Group Asset Management's portfolio in Q1 2026, its #105 holding.
- Smith Group Asset Management first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 9 quarters since.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Smith Group Asset Management's 13F filing for Q1 2026, filed 18 May 2026.